Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients

The George Institute

Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.

Brief summary

Introduction- Hospital acquired infections (HAI) are a major cause of morbidity and mortality and increase health care costs. Critically ill patients are particularly susceptible to these infections and have an even higher mortality. One intervention that has gained much interest in the medical literature for reducing infection rates and deaths from HAIs is selective decontamination of the digestive tract (SDD). SDD involves the application of antibiotic paste to the mouth, throat, stomach and a short course of intravenous antibiotics. The evidence supporting the use of SDD for saving lives and preventing infections is actually quite strong. However, health care professionals in many parts of the world have refrained from using SDD due to fears of the effects of overuse of antibiotics on the frequency of infections with resistant bacteria such as multi-resistant Gram negative organisms, MRSA and Clostridium difficile. SuDDICU is a cross-over, cluster randomised trial comparing the effect of using selective decontamination of the digestive tract (SDD) plus standard care, to standard care alone on hospital mortality in patients receiving mechanical ventilation in the intensive care unit (ICU). Secondary outcomes include an ecological assessment and a long-term health economic analysis.

Source: ClinicalTrials.gov (U.S. National Library of Medicine), data processed 2026-10-29T09:00:05; modifications: selected fields only; whitespace normalized; brief summary truncated to 2,000 characters. Not a U.S. Government endorsement.

Trial details

acronym
SuDDICU
status
COMPLETED
phase
PHASE3
study type
INTERVENTIONAL
enrollment
20010
sponsor
The George Institute
conditions
Critical Illness; Sepsis; Septic Shock; Ventilator Associated Pneumonia
interventions
DRUG: SDD Oral Paste; DRUG: SDD Gastric Suspension; DRUG: Intravenous Antibiotic
start date
2017-05-01
start date type
ACTUAL
primary completion date
2023-04-26
has results
false
data source
ClinicalTrials.gov
data processed
2026-10-29T09:00:05
modifications
selected fields only; whitespace normalized; brief summary truncated to 2,000 characters

Record

Archive ID
nct:NCT02389036
Published
Mar 17, 2015
Updated
Aug 14, 2023
Venue
ClinicalTrials.gov
ClinicalTrials.gov
NCT02389036
Categories
Critical Illness, Sepsis, Septic Shock, Ventilator Associated Pneumonia
License
ClinicalTrials.gov terms (attribution, processing date, modifications noted)
Provenance
clinicaltrials

Topics